SA Wang, A Orazi, J Gotlib, A Reiter… - American journal of …, 2023 - Wiley Online Library
Based on new data and increased understanding of disease molecular genetics, the international consensus classification (ICC) has made several changes in the diagnosis and …
JJ Lyons, G Greiner, G Hoermann… - The Journal of Allergy and …, 2022 - Elsevier
The measurement of mast cell tryptase levels in serum has found utility in the diagnosis and management of both clonal mast cell disorders and severe mast cell–dependent systemic …
M Kačar, M Rijavec, J Šelb… - Clinical & Experimental …, 2023 - Wiley Online Library
The association between Hymenoptera venom‐triggered anaphylaxis (HVA) and clonal mast cell‐related disorders (cMCD) has been known for decades. However, recent …
T Gulen - Immunology and Allergy Clinics, 2023 - immunology.theclinics.com
Mast cells (MCs) are stationary cells and are present in all vascularized tissues. 1–4 Although their physiologic role is thought to be supporting innate immunity, wound healing …
J Ungerstedt, C Ljung, M Klimkowska, T Gülen - Cancers, 2022 - mdpi.com
Simple Summary The term mastocytosis denotes a heterogeneous group of rare disorders characterized by abnormal accumulation and activation of mast cells in various organs …
Our knowledge of biology and mast cell (MC) function, as well as disorders associated with the pathologic activation of MCs, has evolved over the last few decades. Anaphylaxis, mast …
NA Boggs, I Tanasi, K Hartmann, R Zanotti… - The Journal of Allergy …, 2024 - Elsevier
Patients with Hymenoptera venom allergy (HVA), especially those with severe anaphylaxis, frequently have concomitant clonal mast cell disease (MCD) in the form of systemic …
Timely diagnosis of systemic mastocytosis (SM) remains challenging because of care heterogeneity. We implemented a standardized approach for SM screening and diagnosis …
T Gulen - Current Allergy and Asthma Reports, 2024 - Springer
Abstract Purpose of Review The current article aims to provide a comprehensive update on diagnostic criteria for mast cell activation syndrome (MCAS), addressing challenges in …